Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Prepaid Assets: 2010-2025

Historic Prepaid Assets for Ironwood Pharmaceuticals (IRWD) over the last 15 years, with Sep 2025 value amounting to $13.1 million.

  • Ironwood Pharmaceuticals' Prepaid Assets fell 7.93% to $13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year decrease of 7.93%. This contributed to the annual value of $11.9 million for FY2024, which is 0.74% down from last year.
  • As of Q3 2025, Ironwood Pharmaceuticals' Prepaid Assets stood at $13.1 million, which was up 2.65% from $12.7 million recorded in Q2 2025.
  • Ironwood Pharmaceuticals' 5-year Prepaid Assets high stood at $22.5 million for Q2 2023, and its period low was $7.0 million during Q3 2022.
  • For the 3-year period, Ironwood Pharmaceuticals' Prepaid Assets averaged around $14.1 million, with its median value being $13.1 million (2025).
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Prepaid Assets surged by 158.34% in 2023, and later crashed by 35.34% in 2024.
  • Quarterly analysis of 5 years shows Ironwood Pharmaceuticals' Prepaid Assets stood at $8.7 million in 2021, then declined by 11.21% to $7.7 million in 2022, then surged by 55.70% to $12.0 million in 2023, then decreased by 0.74% to $11.9 million in 2024, then decreased by 7.93% to $13.1 million in 2025.
  • Its last three reported values are $13.1 million in Q3 2025, $12.7 million for Q2 2025, and $12.3 million during Q1 2025.